Skip to content


Sancuso, Sustol (granisetron) is a small molecule pharmaceutical. Granisetron was first approved as Sancuso on 2008-09-12. It has been approved in Europe to treat neoplasms and vomiting. Granisetron hydrochloride's patents are valid until 2025-01-22 (FDA).
Trade Name Sancuso
Common Name Granisetron
Indication neoplasms, vomiting
Drug Class Serotonin 5-HT3 antagonists
Get full access now